Treatment of acute myeloid leukemia (AML) with venetoclax failure Grant US-11793802-B2 United States of America 24 Oct 2023
Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1… Grant US-11497756-B2 United States of America 15 Nov 2022
Alvocidib prodrugs and their use as protein kinase inhibitors Grant US-11279694-B2 United States of America 22 Mar 2022
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer Grant US-11034710-B2 United States of America 15 Jun 2021
Combination therapies for treatment of cancer Grant US-10835537-B2 United States of America 17 Nov 2020
Combination therapies for treatment of cancer Grant US-10682356-B2 United States of America 16 Jun 2020
Predicting response to alvocidib by mitochondrial profiling Grant US-10624880-B2 United States of America 21 Apr 2020
Combination therapies for treatment of cancer Grant US-10568887-B2 United States of America 25 Feb 2020
Profiling peptides and methods for sensitivity profiling Grant US-10422788-B2 United States of America 24 Sep 2019
COMBINATION THERAPIES FOR TREATMENT OF CANCER Application EP-3331510-A4 European Patent Office 03 Apr 2019